The auditory science company taps the veteran audiologist and biotech executive to lead its North American growth strategy, with a focus on expanding clinical and R&D partnerships. Cilcare , a biopharmaceutical company specializing in auditory science, has named Kevin Franck, PhD, MBA, as head of US, general manager North America....
Continue reading at Hearing Review
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a leadership appointment at a biopharmaceutical company with no direct implication for clinical practice.
The appointment of a credentialed audiologist to lead North American operations at a hearing-focused biopharma signals growing cross-sector movement between clinical audiology and drug development.
- 01Cilcare has named Kevin Franck, PhD (audiologist and biotech executive) as Head of US and General Manager, North America.
- 02Franck will lead Cilcare's North American regional growth strategy.
- 03His mandate includes building clinical and R&D partnerships across the region.
- 04Cilcare is a biopharmaceutical company specializing in auditory science.
